Arts Way Manufacturing Co Inc
ARTW Nasdaq Farm Machinery & Equipment Financials FY2014βFY2025
What Arts Way Manufacturing Co Inc does
No business description yet.
- Legal name
- ARTS WAY MANUFACTURING CO INC
- Fiscal year ends
- November 30, 2025
- Latest annual report
- 10-K Β· Feb 12, 2026
- Accession Β· CIK
- 0001437749-26-003904
0000007623
Revenue and margins
Arts Way Manufacturing Co Inc had $23.0M of revenue in fiscal 2025, down 6.2% on the year before.
Net income and earnings per share
From fiscal 2014 to 2025, diluted EPS grew β1.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$1.5M in fiscal 2025, β6.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Arts Way Manufacturing Co Inc returned $0.0M to shareholders in fiscal 2025. The diluted share count rose 0.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably Arts Way Manufacturing Co Inc can carry it.
| Fiscal year end | FY19 | FY20 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Debt incl. finance leases | $2.4M | $2.8M | $3.7M | $2.9M | $3.2M |
| Net debt / EBITDA | β | β | 3.3x | 2.1x | 2.9x |
| Debt / equity | 0.2x | 0.3x | 0.2x | 0.2x | 0.2x |
| Interest coverage | β4.2x | β12.8x | 1.7x | 0.8x | 0.8x |
| Current ratio | 2.2x | 1.7x | 1.6x | 2.0x | 2.3x |
| Quick ratio | 0.7x | 0.4x | 0.4x | 0.4x | 0.5x |
| Total assets | $19.3M | $18.8M | $24.4M | $21.2M | $22.5M |
| Total liabilities | $7.6M | $8.9M | $12.8M | $9.1M | $9.2M |
| Shareholders' equity | $11.8M | $9.9M | $11.6M | $12.1M | $13.3M |
| Net debt (β = net cash) | $2.4M | $2.8M | $3.7M | $2.8M | $3.1M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY14 | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 9 | 3 / 9 | 4 / 9 | 3 / 9 | 6 / 9 | 2 / 9 | β / 3 | 8 / 9 | 3 / 9 |
| Accruals ratio | β3.1% | β2.6% | β10.9% | β9.2% | β9.9% | β11.0% | β6.5% | 4.9% | β10.2% | 8.9% |
| Altman Z'' | 6.18 | 5.79 | 6.11 | 5.84 | 4.16 | 4.66 | 2.33 | 3.57 | 4.66 | 5.26 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY14 | FY15 | FY16 | FY17 | FY18 | FY19 | FY20 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $36.2M | $26.3M | $21.6M | $20.7M | $19.7M | $22.9M | $22.4M | $25.0M | $24.5M | $23.0M |
| Gross profit | $8.7M | $6.9M | $5.3M | $4.1M | $3.5M | $3.9M | $2.4M | $6.6M | $7.3M | $6.3M |
| Research and development | $0.2M | $0.2M | $0.1M | $0.2M | $0.2M | $0.1M | $0.2M | $0.2M | $0.2M | $0.2M |
| Operating income | $1.7M | β$0.1M | β$0.4M | β$1.7M | β$3.1M | β$1.5M | β$3.9M | $0.5M | $0.5M | $0.3M |
| Interest expense | $0.4M | $0.3M | $0.2M | $0.3M | $0.3M | $0.4M | $0.3M | $0.3M | $0.6M | $0.4M |
| Pretax income | $1.3M | β$0.5M | β$0.5M | β$1.8M | β$3.8M | β$1.8M | β$3.0M | $0.3M | β$0.1M | $1.4M |
| Income tax | $0.4M | β$0.2M | β$0.1M | β$0.4M | β$0.5M | β$0.3M | β$0.9M | $0.1M | β$0.0M | $0.4M |
| Net income | $0.9M | β$0.6M | β$0.8M | β$1.6M | β$3.4M | β$1.4M | β$2.1M | $0.2M | $0.3M | $1.0M |
| Diluted EPS | $0.23 | β$0.14 | β$0.20 | β$0.39 | β$0.81 | β$0.33 | β$0.48 | $0.05 | $0.06 | $0.20 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $1.9M | $0.3M | $2.4M | $0.7M | β$1.1M | $0.8M | β$0.9M | β$1.0M | $2.6M | β$0.9M |
| Capital expenditure | $0.6M | $0.2M | $0.3M | $0.5M | $0.4M | $0.4M | $0.7M | $0.6M | $0.7M | $0.6M |
| Free cash flow | $1.3M | $0.0M | $2.1M | $0.2M | β$1.6M | $0.4M | β$1.5M | β$1.6M | $1.9M | β$1.5M |
| Depreciation and amortization | $0.9M | $0.8M | $0.7M | $0.7M | $1.0M | $1.0M | $0.8M | $0.6M | $0.9M | $0.8M |
| Stock-based compensation | $0.0M | $0.0M | $0.1M | $0.1M | $0.2M | $0.2M | $0.2M | $0.3M | $0.2M | $0.2M |
| Share buybacks | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | β | $0.2M | β | β | β | β | β | β | β | β |
| Dividends and buybacks | β | $0.2M | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.5M | $0.4M | $1.1M | $0.2M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total debt | $7.2M | $5.9M | $3.9M | $3.6M | $2.8M | $2.4M | $2.8M | $2.7M | $2.1M | $2.5M |
| Finance lease liabilities | β | β | β | β | β | β | β | $1.0M | $0.8M | $0.7M |
| Current assets | $20.1M | $20.0M | $17.6M | $14.4M | $12.1M | $11.4M | $10.3M | $15.1M | $13.1M | $14.8M |
| Current liabilities | $6.5M | $7.3M | $7.1M | $5.0M | $5.8M | $5.2M | $6.2M | $9.4M | $6.6M | $6.4M |
| Inventory | $15.1M | $15.2M | $13.5M | $12.0M | $10.3M | $7.8M | $7.8M | $11.0M | $10.3M | $11.7M |
| Property and equipment, net | $11.7M | $7.8M | $7.4M | $5.9M | $5.6M | $5.4M | $5.2M | $5.1M | $5.2M | $5.1M |
| Goodwill | $1.0M | $0.4M | $0.4M | $0.4M | $0.4M | β | β | β | β | β |
| Total assets | $32.8M | $31.3M | $27.2M | $24.4M | $21.3M | $19.3M | $18.8M | $24.4M | $21.2M | $22.5M |
| Total liabilities | $13.6M | $12.8M | $9.8M | $8.4M | $8.3M | $7.6M | $8.9M | $12.8M | $9.1M | $9.2M |
| Preferred stock | $0.0M | $0.0M | β | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $19.3M | $18.5M | $17.5M | $16.0M | $13.0M | $11.8M | $9.9M | $11.6M | $12.1M | $13.3M |
| Margins | ||||||||||
| Gross margin | 24.1% | 26.3% | 24.7% | 19.7% | 17.8% | 17.2% | 10.7% | 26.4% | 29.8% | 27.3% |
| Operating margin | 4.6% | β0.3% | β2.0% | β8.3% | β15.7% | β6.5% | β17.4% | 2.1% | 1.9% | 1.3% |
| EBITDA margin | 7.1% | 2.8% | 1.1% | β4.9% | β10.8% | β2.2% | β13.8% | 4.6% | 5.4% | 4.7% |
| Net margin | 2.6% | β2.1% | β3.8% | β7.9% | β17.2% | β6.2% | β9.4% | 0.9% | 1.3% | 4.5% |
| FCF margin | 3.6% | 0.2% | 9.8% | 1.1% | β7.9% | 1.6% | β6.9% | β6.4% | 7.8% | β6.7% |
| Returns | ||||||||||
| Return on capital | 4.6% | β0.3% | β1.7% | β7.0% | β15.5% | β8.3% | β24.3% | 2.9% | 2.6% | 1.3% |
| Return on capital employed | 6.3% | β0.3% | β2.1% | β8.9% | β19.9% | β10.6% | β30.9% | 3.5% | 3.2% | 1.8% |
| Return on equity | 4.9% | β3.0% | β4.6% | β9.8% | β23.3% | β11.4% | β19.4% | 1.8% | 2.6% | 8.1% |
| Return on assets | 2.8% | β1.7% | β2.8% | β6.3% | β14.8% | β7.0% | β11.0% | 0.9% | 1.3% | 4.7% |
| Return on tangible equity | 5.1% | β3.1% | β4.8% | β10.5% | β26.7% | β12.0% | β21.2% | 1.8% | 2.5% | 7.8% |
| Growth | ||||||||||
| Revenue growth | β | β27.2% | β18.1% | β3.9% | β4.8% | 16.0% | β2.1% | β | β1.9% | β6.2% |
| Net income growth | β | β159.6% | β | β | β | β | β | β | 44.6% | 236.7% |
| EPS growth | β | β160.9% | β | β | β | β | β | β | 20.0% | 233.3% |
| FCF growth | β | β96.5% | 4,482.0% | β88.9% | β764.3% | β | β529.5% | β | β | β180.5% |
| Share count change | β | 0.1% | 1.0% | 1.3% | 1.2% | 1.8% | 2.7% | β | 11.9% | 0.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | 2.6x | 7.4x | 11.8x | β | β | β | β | 3.3x | 2.1x | 2.9x |
| Debt / equity | 0.4x | 0.3x | 0.2x | 0.2x | 0.2x | 0.2x | 0.3x | 0.2x | 0.2x | 0.2x |
| Interest coverage | 4.7x | β0.3x | β1.7x | β5.4x | β10.2x | β4.2x | β12.8x | 1.7x | 0.8x | 0.8x |
| Current ratio | 3.1x | 2.7x | 2.5x | 2.9x | 2.1x | 2.2x | 1.7x | 1.6x | 2.0x | 2.3x |
| Quick ratio | 0.8x | 0.7x | 0.6x | 0.5x | 0.3x | 0.7x | 0.4x | 0.4x | 0.4x | 0.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.8% | 0.9% | 1.3% | 2.5% | 2.2% | 2.0% | 3.1% | 2.5% | 3.0% | 2.7% |
| Stock comp / revenue | 0.0% | 0.1% | 0.4% | 0.5% | 1.0% | 0.9% | 1.1% | 1.1% | 0.7% | 0.8% |
| Payouts / FCF | β | 440.0% | β | 2.7% | β | 5.3% | β | β | 2.0% | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 3.0 | 4.0 | 3.0 | 6.0 | 2.0 | β | 8.0 | 3.0 |
| Altman Z'' | 6.2 | 5.8 | 6.1 | 5.8 | 4.2 | 4.7 | 2.3 | 3.6 | 4.7 | 5.3 |
| Accruals ratio | β3.1% | β2.6% | β10.9% | β9.2% | β9.9% | β11.0% | β6.5% | 4.9% | β10.2% | 8.9% |
Source: SEC EDGAR XBRL filings (CIK 0000007623). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.